“Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience”, acmcr, vol. 6, no. 3, pp. 442–451, May 2022, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22626